Low penetrance, potentially deleterious ATM missense variants, which were associated with an increased risk for breast cancer, have been found in other breast cancer populations (Scott et al. 2002; Thorstenson et al. 2003; Graña et al. 2011). This evidence concerns the gene ATM and breast cancer.